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www.sciencedirect.comEDITORIALThe Holy Grail of medicine: Era of rejuvenation therapyNanotechnology and nanoengineering are poised to produce
signiﬁcant scientiﬁc and technological advances in diverse
ﬁelds including medicine and dentistry. This science envisages
the design, syntheses, characterization and application of
materials and devices whose smallest functional organization
in at least one-dimension is on the nanometer scale, ranging
from a few to several hundred nanometers. For its applica-
tion particularly in dentistry, these materials and devices
can be designed to interact with cells and tissues at a
molecular (subcellular) level with a high degree of functional
speciﬁcity, thus opening vistas so far unattainable in the ﬁeld.
Nanoengineered materials and devices designed to interact
with cells and tissues or carry out biologically speciﬁc func-
tions should offer a much greater degree of integration be-
tween technology and physiological systems. In turn, this
should eventually translate in to novel clinical applications
and treatment options. At present, applied nanotechnology
to medicine and dentistry is in its infancy, with most of the
research at the basic science level as the ﬁeld attempts to
organize itself. As such, viable clinical applications are still
years away, but despite this the current pace of development
is impressive.
The potential applications of nanotechnology in medicine
are vast. This includes targeted drug delivery, nano-enabled
therapies, imaging and diagnostics. In cancer research, for
example, the ultimate goal is to develop multifunctional
nano-scale devices that act as both imaging agent and antican-
cer therapy. One of the most highly publicized areas of nano-
medicine research involves gold nanoshells to detect and treat
cancerous tumors. Here is a case where detection and therapy
overlap. Nanoshells are particles of silica (glass) completely
coated with gold, made up of a few million atoms. They can
be produced in a range of sizes, with diameters smaller than
100 nm to as large as several hundred nanometers. When in-
jected in to the blood stream, they naturally congregate at
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Production and hosting by Elseviersary. In order to feed their growth, tumors create many blood
vessels (neoangiogenesis) very quickly, so the vessels are often
defective, allowing the nanoshells to slip through vascular
‘‘leaks’’ and gain access to the tumor. Detecting and targeting
tumors by exploiting their surrounding vascular defects is
known as ‘‘enhanced permeability and retention’’ or EPR
effect. A nanoshell captures light and focuses it around itself.
By manipulating the size of the nanoshells, it is possible to
change the way they absorb light. The goal in cancer detection
and therapy is to ‘‘tune’’ the nanoshells to interact with near-
infrared light (NIR). When exposed to NIR, the nanoshells act
like ‘‘a swarm of ﬁre ﬂies’’ and light up the area where they
have congregated (i.e., tumor sites). Once the nanoshells have
completed their imaging tasks, they become therapeutic
agents. The area around the nanoshells heats up and the tumor
‘‘cooks’’ until it is ablated. These claims will have to be closely
scrutinized, as nanoshells will likely take up permanent resi-
dence in the body and it is not clear how or if the body could
excrete them.
‘‘Quantum dots’’ are semiconductor nanoparticles that
have unique optical and electrical properties. When exposed
to light, these nanoparticles emit distinctly different colors
depending on their size (the smaller the quantum dots, the
brighter the color). Although ﬂuorescent dyes have been used
for decades in the human body for biomedical imaging (to
track the effects of cancer drugs, for instance), they are often
imprecise and only visible for short time periods. Fluorescent
quantum dots will provide a brighter, more precise and longer
lasting alternative. Quantum dots can be injected in to cells or
attached to proteins in order to track, label or identify speciﬁc
biomolecules and that they offer the ‘‘ultimate detection sensi-
tivity’’. Quantum dots can stay inside cells for weeks or
months, but virtually nothing is known about how these nano-
particles metabolize inside the body or their routes of
excretion.
Nanotechnology will play a key role in tissue engineering
because it operates on the molecular scale and is capable of
integrating both biological and non-biological materials.
Researchers are using self-assembling nanostructures to create
artiﬁcial collagen (main protein component of bones, skin,
teeth and tendons). Because it is a major structural component
of the tissues and organs, it is hoped that nano-structured arti-
ﬁcial collagen as the three-dimensional scaffolding is needed to
encourage cell regeneration for growing speciﬁc cells, tissues
and organs. Nano-scale materials are being used to develop
102 Editorialsynthetic bone replacement materials with improved durabil-
ity, biocompatibility and strength. Technology to produce syn-
thetic bone replacement material that could be used for bone
grafting or for bioactive coatings on artiﬁcial joints such as
hip and knee replacements and dental implants are being
tested.
As it stands now, the majority of commercial nanoparticle
applications in medicine are geared towards drug delivery.
There are some developments in directing and remotely con-
trolling the functions of nano-probes, for example, driving
magnetic nanoparticles to the tumor and then making them
either to release the drug load or just heating them in order
to destroy the surrounding tissue. The major trend in further
development of nano-materials is to make them multifunc-
tional and controllable by external signals or by local environ-
ment thus essentially turning them in to nano-devices.
Ultimately, every patho-physiological process has a molecular
origin, and it is from this basic fact that the tremendous poten-
tial of nanotechnology applications to medicine and dentistry
arises.Further reading
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